TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency

Genes and Development

Volumn 32, Issue 17-18, 2018, Pages 1161-1174

  Yamazaki, Takashi ^a,d   Liu, Lizhi ^a   Lazarev, Denis ^a   Al Zain, Amr ^a   Fomin, Vitalay ^a   Yeung, Percy Luk ^b   Chambers, Stuart M ^c,e   Lu, Chi Wei ^b   Studer, Lorenz ^c   Manley, James L ^a  

^a Columbia University ^*  (United States)

^b CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^e AMGEN INC   (United States)

Author keywords

Alternative splicing; E2A; Heterogeneous nuclear ribonucleoprotein; Human embryonic stem cell; T cell factor 3

Indexed keywords

E12 PROTEIN; E47 PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS F; ISOPROTEIN; MESSENGER RNA PRECURSOR; TRANSCRIPTION FACTOR 7 LIKE 1; UNCLASSIFIED DRUG; UVOMORULIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CADHERIN; CDH1 PROTEIN, HUMAN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN GROUP F H; MESSENGER RNA; RNA PRECURSOR; TCF3 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EXON; FEMALE; GENE IDENTIFICATION; GENE KNOCKDOWN; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; IN VITRO STUDY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY SEQUENCE; RNA SEQUENCE; CELL LINE; CHEMISTRY; CYTOLOGY; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REGULATORY RNA SEQUENCE;

ALTERNATIVE SPLICING; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CADHERINS; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; EXONS; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP F-H; HUMANS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA PRECURSORS; RNA, MESSENGER;

EID: 85053276864     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.316984.118     Document Type: Article

References (65)

1. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. 2009. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449.
2. Ahn H-J, Lib Jang K, Yeom S, Kwak J, Shin Kim S. 2016. Hepatitis B virus X protein induces epithelial-mesenchymal transition by repressing E-cadherin expression via upregulation of E12/E47. J Gen Virol 97: 134-143.
3. Beck K, Peak MM, Ota T, Nemazee D, Murre C. 2009. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J Exp Med 206: 2271-2284.
4. Behrens J, Löwrick O, Klein-Hitpass L, Birchmeier W. 1991. The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci 88: 11495-11499.
5. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. 2005. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896.
6. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sade-lain M, Studer L. 2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27: 275-280.
7. Chia N-Y, Chan Y-S, Feng B, Lu X, Orlov YL, Moreau D, Kumar P, Yang L, Jiang J, Lau M-S, et al. 2010. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468: 316-320.
8. Chou M-Y, Rooke N, Turck CW, Black DL. 1999. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol Cell Biol 19: 69-77.
9. Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA. 2008. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev 22: 746-755.
10. Conlon EG, Lu L, Sharma A, Yamazaki T, Tang T, Shneider NA, Manley JL. 2016. The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. Elife 5: e17820.
11. Cunningham TJ, Yu MS, McKeithan WL, Spiering S, Carrette F, Huang C-T, Bushway PJ, Tierney M, Albini S, Giacca M, et al. 2017. Id genes are essential for early heart formation. Genes Dev 31: 1325-1338.
12. Eastham AM, Spencer H, Soncin F, Ritson S, Merry CLR, Stern PL, Ward CM. 2007. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 67: 11254-11262.
13. Gabut M, Samavarchi-Tehrani P, Wang X, Slobodeniuc V, O’Han-lon D, Sung H-K, Alvarez M, Talukder S, Pan Q, Mazzoni EO, et al. 2011. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 147: 132-146.
14. Gopalakrishna-Pillai S, Iverson LE. 2011. A DNMT3B alternatively spliced exon and encoded peptide are novel biomarkers of human pluripotent stem cells. PLoS ONE 6: e20663.
15. Grammatikakis I, Zhang P, Panda AC, Kim J, Maudsley S, Abdel-mohsen K, Yang X, Martindale JL, Motiño O, Hutchison ER, et al. 2016. Alternative splicing of neuronal differentiation factor TRF2 regulated by HNRNPH1/H2. Cell Rep 15: 926-934.
16. Han K, Yeo G, An P, Burge CB, Grabowski PJ. 2005. A combinatorial code for splicing silencing: UAGG and GGGG motifs. PLoS Biol 3: e158.
17. Han H, Irimia M, Ross PJ, Sung H-K, Alipanahi B, David L, Goli-pour A, Gabut M, Michael IP, Nachman EN, et al. 2013. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. Nature 498: 241-245.
18. Huang T-S, Li L, Moalim-Nour L, Jia D, Bai J, Yao Z, Bennett SAL, Figeys D, Wang L. 2015. A regulatory network involving β-Catenin, e-Cadherin, PI3k/Akt, and Slug balances self-renewal and differentiation of human pluripotent stem cells in response to Wnt signaling. Stem Cells 33: 1419-1433.
19. Huang H, Zhang J, Harvey SE, Hu X, Cheng C. 2017. RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF. Genes Dev 31: 2296-2309.
20. ′ end formation to DNA damage and tumor suppression. Cell 104: 743-753.
21. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
22. Li X, Qian X, Peng L-X, Jiang Y, Hawke DH, Zheng Y, Xia Y, Lee J-H, Cote G, Wang H, et al. 2016. A splicing switch from keto-hexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation. Nat Cell Biol 18: 561-571.
23. Lu X, Göke J, Sachs F, Jacques P-É, Liang H, Feng B, Bourque G, Bubulya PA, Ng H-H. 2013. SON connects the splicing-regula-tory network with pluripotency in human embryonic stem cells. Nat Cell Biol 15: 1141-1152.
24. Mandler MD, Ku L, Feng Y. 2014. A cytoplasmic quaking I isoform regulates the hnRNP F/H-dependent alternative splicing pathway in myelinating glia. Nucleic Acids Res 42: 7319-7329.
25. Mayshar Y, Rom E, Chumakov I, Kronman A, Yayon A, Benve-nisty N. 2008. Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal. Stem Cells 26: 767-774.
26. Merrill BJ, Gat U, DasGupta R, Fuchs E. 2001. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev 15: 1688-1705.
27. Merrill BJ, Pasolli HA, Polak L, Rendl M, García-García MJ, Anderson KV, Fuchs E. 2004. Tcf3: a transcriptional regulator of axis induction in the early embryo. Development 131: 263-274.
28. Min H, Chan RC, Black DL. 1995. The generally expressed hnRNP F is involved in a neural-specific pre-mRNA splicing event. Genes Dev 9: 2659-2671.
29. Miyazaki M, Miyazaki K, Chen K, Jin Y, Turner J, Moore AJ, Saito R, Yoshida K, Ogawa S, Rodewald H-R, et al. 2017. The E-Id protein axis specifies adaptive lymphoid cell identity and suppresses thymic innate lymphoid cell development. Immunity 46: 818-834.e4.
30. Murre C, McCaw PS, Baltimore D. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56: 777-783.
31. Murry CE, Keller G. 2008. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132: 661-680.
32. Nguyen H, Rendl M, Fuchs E. 2006. Tcf3 governs stem cell features and represses cell fate determination in skin. Cell 127: 171-183.
33. Ohgushi M, Matsumura M, Eiraku M, Murakami K, Aramaki T, Nishiyama A, Muguruma K, Nakano T, Suga H, Ueno M, et al. 2010. Molecular pathway and cell state responsible for disso-ciation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 7: 225-239.
34. Pereira L, Yi F, Merrill BJ. 2006. Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. Mol Cell Biol 26: 7479-7491.
35. Pérez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA, Cano A. 2001. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem 276: 27424-27431.
36. Pfurr S, Chu Y-H, Bohrer C, Greulich F, Beattie R, Mammadzada K, Hils M, Arnold SJ, Taylor V, Schachtrup K, et al. 2017. The E2A splice variant E47 regulates the differentiation of projection neurons via p57(KIP2) during cortical development. Development 144: 3917-3931.
37. Piva F, Giulietti M, Burini AB, Principato G. 2012. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum Mutat 33: 81-85.
38. Prudencio M, Belzil VV, Batra R, Ross CA, Gendron TF, Pregent LJ, Murray ME, Overstreet KK, Piazza-Johnston AE, Desaro P, et al. 2015. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci 18: 1175-1182.
39. Rao S, Zhen S, Roumiantsev S, McDonald LT, Yuan G-C, Orkin SH. 2010. Differential roles of Sall4 isoforms in embryonic stem cell pluripotency. Mol Cell Biol 30: 5364-5380.
40. Rauch J, Moran-Jones K, Albrecht V, Schwarzl T, Hunter K, Gires O, Kolch W. 2011. c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway. Cancer Res 71: 4664-4674.
41. Redmer T, Diecke S, Grigoryan T, Quiroga-Negreira A, Birchmeier W, Besser D. 2011. E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep 12: 720-726.
42. Salomonis N, Schlieve CR, Pereira L, Wahlquist C, Colas A, Zam-bon AC, Vranizan K, Spindler MJ, Pico AR, Cline MS, et al. 2010. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc Natl Acad Sci 107: 10514-10519.
43. Sato N, Sanjuan IM, Heke M, Uchida M, Naef F, Brivanlou AH. 2003. Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol 260: 404-413.
44. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, et al. 2012. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490: 116-120.
45. Shen Y, Hirsch DS, Sasiela CA, Wu WJ. 2008. Cdc42 regulates E-cadherin ubiquitination and degradation through an epidermal growth factor receptor to Src-mediated pathway. J Biol Chem 283: 5127-5137.
46. Shen S, Park JW, Huang J, Dittmar KA, Lu ZX, Zhou Q, Carstens RP, Xing Y. 2012. MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-seq data. Nucleic Acids Res 40: e61.
47. Sierra RA, Hoverter NP, Ramirez RN, Vuong LM, Mortazavi A, Merrill BJ, Waterman ML, Donovan PJ. 2018. TCF7L1 suppresses primitive streak gene expression to support human embryonic stem cell pluripotency. Development 145: dev161075.
48. Sun XH, Baltimore D. 1991. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64: 459-470.
49. Tam W-L, Lim CY, Han J, Zhang J, Ang Y-S, Ng H-H, Yang H, Lim B. 2008. T-cell factor 3 regulates embryonic stem cell pluripotency and self-renewal by the transcriptional control of multiple lineage pathways. Stem Cells 26: 2019-2031.
50. Thomson JA. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
51. Tiwari I, Yoon M-H, Park B-J, Jang KL. 2015. Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels. Cancer Lett 362: 131-138.
52. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L. 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7: 562-578.
53. Venables JP, Lapasset L, Gadea G, Fort P, Klinck R, Irimia M, Vignal E, Thibault P, Prinos P, Chabot B, et al. 2013. MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. Nat Commun 4: 2480.
54. Vossaert L, O’Leary T, Van Neste C, Heindryckx B, Vandesom-pele J, De Sutter P, Deforce D. 2013. Reference loci for RT-qPCR analysis of differentiating human embryonic stem cells. BMC Mol Biol 14: 21.
55. Wang L-H, Baker NE. 2015. E proteins and ID proteins: helix-loop-helix partners in development and disease. Dev Cell 35: 269-280.
56. Wang E, Aslanzadeh V, Papa F, Zhu H, de la Grange P, Cambi F. 2012. Global profiling of alternative splicing events and gene expression regulated by hnRNPH/F. PLoS ONE 7: e51266.
57. Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, Takahashi JB, Nishikawa S, Nishikawa S, Muguruma K, et al. 2007. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25: 681-686.
58. Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook A, Kemler R, Smith A. 2011. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol 13: 838-845.
59. Wu D, Seita Y, Zhang X, Lu C-W, Roth MJ. 2012. Antibody-direct-ed lentiviral gene transduction for live-cell monitoring and selection of human iPS and hES cells. PLoS ONE 7: e34778.
60. Xiao X, Wang Z, Jang M, Nutiu R, Wang ET, Burge CB. 2009. Splice site strength-dependent activity and genetic buffering by poly-G runs. Nat Struct Mol Biol 16: 1094-1100.
61. Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, Whitaker JW, Tian S, Hawkins RD, Leung D, et al. 2013. Epige-nomic analysis of multilineage differentiation of human embryonic stem cells. Cell 153: 1134-1148.
62. Xu R-H, Chen X, Li DS, Li R, Addicks GC, Glennon C, Zwaka TP, Thomson JA. 2002. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 20: 1261-1264.
63. Xu J, Lu Z, Xu M, Pan L, Deng Y, Xie X, Liu H, Ding S, Hurd YL, Pasternak GW, et al. 2014. A heroin addiction severity-associ-ated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions. J Neurosci 34: 11048-11066.
64. Yi F, Pereira L, Merrill BJ. 2008. Tcf3 functions as a steady-state limiter of transcriptional programs of mouse embryonic stem cell self-renewal. Stem Cells 26: 1951-1960.
65. Yi F, Pereira L, Hoffman JA, Shy BR, Yuen CM, Liu DR, Merrill BJ. 2011. Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal. Nat Cell Biol 13: 762-770.